Cargando…
Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation
BACKGROUND: Intravenous immunoglobulin (IVIG) proved to be an efficient anti-inflammatory treatment for a growing number of neuroinflammatory diseases and protects against the development of experimental autoimmune encephalomyelitis (EAE), a widely used animal model for multiple sclerosis (MS). METH...
Autores principales: | Quast, Isaak, Keller, Christian W., Weber, Patrick, Schneider, Christoph, von Gunten, Stephan, Lünemann, Jan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758141/ https://www.ncbi.nlm.nih.gov/pubmed/26893156 http://dx.doi.org/10.1186/s12974-016-0506-x |
Ejemplares similares
-
IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis
por: Benkhoucha, Mahdia, et al.
Publicado: (2012) -
Historical Aspects of Polyclonal IgG Preparations
por: Wahn, Volker, et al.
Publicado: (2017) -
Essential Role of NK Cells in IgG Therapy for Experimental Autoimmune Encephalomyelitis
por: Chong, Wai Po, et al.
Publicado: (2013) -
TCDD Inhibition of IgG1 Production in Experimental Autoimmune Encephalomyelitis (EAE) and In Vitro
por: Nicaise, Ashleigh J., et al.
Publicado: (2022) -
Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis
por: Saini, Harleen, et al.
Publicado: (2013)